ACHC vs EIKN: fair value comparison
Acadia Healthcare Company, Inc. and Eikon Therapeutics, Inc. · Updated 2026-10-19
EIKN has no fair-value estimate yet: no usable analyst consensus or too few reported quarters. Within Healthcare, ACHC currently ranks higher by quality score.
| ACHC | EIKN | |
|---|---|---|
| Verdict | Fairly valued | No estimate yet |
| Last price | $29.98 | $7.42 |
| 12-month range | $11.68–$35.61 | $7.41–$15.00 |
| Rank by discount to fair value | #105 of 108 Healthcare | — |
| Rank by quality score | #285 of 301 Healthcare | #287 of 301 Healthcare |
| Quality grade | F | F |
| Leverage | Moderate | Moderate |
| Margin trend | Contracting | — |
| Revenue growth | Modest | — |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | — |
| 52-week position | The top quarter | The bottom quarter |
Full single-stock breakdowns: ACHC fair value analysis · EIKN fair value analysis